In this context, the hypothesis of whether DPP-4 inhibition increases susceptibility to COVID-19 infection and whether it reduces significant complications such as ARDS, which represents the leading cause of death in COVID-19 patients, has been brought up [19]. The gene discussed is DPP4; the disease is COVID-19.